927891-86-9Relevant articles and documents
HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS
-
Page/Page column 48, (2010/03/04)
The invention relates to compounds of general formula (I), corresponding enantiomeric, diastereomeric and/or tautomeric forms thereof as well as pharmaceutically acceptable salts thereof and the prodrugs of said compounds. The invention also relates to the use of said compounds as binding partners for 5-HT5 receptors for treating diseases that are modulated by a 5-HT5 receptor activity, in particular, for treating neurodegenerative and neuropsychiatric disorders as well as signs, symptoms and dysfunctions.
Rapid and Efficient Synthesis of 1H-Indol-2-yl-1H-quinolin-2-ones
Kuethe, Jeffrey T.,Wong, Audrey,Davies, Ian W.
, p. 3975 - 3978 (2007/10/03)
(Equation Presented) A concise and efficient synthesis of the novel indol-2-yl-1H-quinolin-2-one ring system found in the potent and selective KDR kinase inhibitors 1-3 is presented.